Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Moleculin Biotech, Inc. (MBRX)
USD2.31
+0.05 (+2.21%)
US NASDAQ Healthcare Biotechnology
Address
5300 Memorial Drive 77007
Houston, TX, US
Houston, TX, US
CEO
Walter V. Klemp
Website
moleculin.com
IPO
2016-06-02
CIK 1659617 ISIN US60855D4088
Description
Moleculin Biotech, Inc. is a clinical-stage pharmaceutical company dedicated to advancing therapeutic candidates designed to combat highly aggressive cancers and viral infections. Their primary investigational drug, Annamycin, is currently undergoing Phase 1/2 clinical trials. These trials aim to assess its efficacy against acute myeloid leukemia (AML) that has relapsed or is resistant to prior therapies, as well as malignancies that have spread to the lungs. WP1066, a prominent immune/transcription modulator for the company, is presently in Phase I studies, targeting both adult and pediatric brain tumors, pancreatic cancer, and other types of aggressive malignancies. Further, the firm is developing WP1220, an analog of WP1066, intended for topical application in treating cutaneous T-cell lymphoma. Another compound, WP1122, is under development for glioblastoma multiforme and COVID-19. Moleculin Biotech has established collaboration agreements and partnerships with organizations such as MD Anderson, Animal Life Sciences, LLC, and WPD Pharmaceuticals Sp z.o.o. The company was founded in 2015 and maintains its principal offices in Houston, Texas.
News Sentiment (7d)
Based on only 2 articles — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD2.31
+0.05 (+2.21%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
500.8K
Beta
1.75
Float Shares
1.18M
Free Float %
97.9%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.80% | -12.35% | -11.65% | -49.31% | -79.72% | -33.53% | -91.14% | -99.05% | -99.82% | -99.99% | -99.99% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (4 ratings, all time)
Buy
Price Targets & DCF
Current price
2.31
DCF (Unlevered)
0.46
-80.3%
DCF (Levered)
0.72
-68.9%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-16.58
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
3 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%—
-
EPS growth Biotechnology: +29.7%+82.0% ★ Q1'26: +99.8% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%—
-
EBIT margin Biotechnology: +0.0%—
-
ROIC Biotechnology: -16.1%-387.0% Q1'26: +0.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+8,501.3% Q1'26: +1,103,588.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.01× Q1'26: -0.01× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2018 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 2 EPS Ana. |
Dec 2027 3 Rev. Ana. 2 EPS Ana. |
Dec 2028 2 Rev. Ana. 2 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|
| Revenue |
—
est: 38.4K (-100.0%)
|
—
|
—
est: 34.43M (-100.0%)
|
71.42M
71.42M – 71.42M
+107.4% YoY
|
41.96M
41.96M – 41.96M
-41.2% YoY
|
87.01M
87.01M – 87.01M
+107.4% YoY
|
51.99M
51.99M – 51.99M
-40.2% YoY
|
120.37M
120.37M – 120.37M
+131.5% YoY
|
| EBITDA |
-14.96M
est: -14.67M (-1.9%)
|
-26.52M
|
-25.01M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EBIT |
-15.06M
est: -14.75M (-2.1%)
|
-26.64M
|
-25.10M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| Net Income |
-11.88M
est: -11.31M (-5.0%)
|
-21.76M
est: -26.18M (+16.9%)
|
-33.56M
est: -430.59M (+92.2%)
|
-58.95M
-67.39M – -50.51M
+86.3% YoY
|
-45.47M
-52.29M – -38.65M
+22.9% YoY
|
-33.56M
-57.21M – -27.01M
+26.2% YoY
|
11.37M
11.37M – 11.37M
+133.9% YoY
|
69.42M
69.42M – 69.42M
+510.4% YoY
|
| SGA |
5.30M
|
8.79M
|
9.12M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EPS |
-1,031.50
est: -1,046.25 (+1.4%)
|
-158.00
est: -190.08 (+16.9%)
|
-28.42
est: -36.35 (+21.8%)
|
-4.98
-5.69 – -4.26
+86.3% YoY
|
-3.84
-4.41 – -3.26
+22.8% YoY
|
-3.56
-4.83 – -2.28
+7.5% YoY
|
0.96
0.96 – 0.96
+127.0% YoY
|
5.86
5.86 – 5.86
+510.4% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-08 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-07 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-06 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-05 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-04 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-01 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-30 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-29 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-28 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-27 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-24 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-23 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-22 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-21 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-20 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-17 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-16 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
Owner's Earnings history not available.
Owner alignment
Owner's Earnings TTM
—
OE per share TTM
—
Owner's Yield
—
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
—
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
24
Total invested
412.7K
Insider transactions (90d)
0
Beneficial owners (>5%)
18
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Alex Noah Investors, Inc. | 4.79M | 7.52% | — | 4.79M | — | — | CO | Illinois | 2020-11-13 | ↗ |
| 2 | Jonathan I. Cope | 4.79M | 7.52% | — | 4.79M | — | — | IN | United States | 2020-11-13 | ↗ |
| 3 | Joshua B. Scheinfeld | 4.79M | 7.52% | — | 4.79M | — | — | IN | United States | 2020-11-13 | ↗ |
| 4 | Lincoln Park Capital Fund, LLC | 4.79M | 7.52% | — | 4.79M | — | — | OO | Illinois | 2020-11-13 | ↗ |
| 5 | Lincoln Park Capital, LLC | 4.79M | 7.52% | — | 4.79M | — | — | OO | Illinois | 2020-11-13 | ↗ |
| 6 | Rockledge Capital Corporation | 4.79M | 7.52% | — | 4.79M | — | — | CO | Texas | 2020-11-13 | ↗ |
| 7 | Armistice Capital, LLC | 3.32M | 9.99% | — | 3.32M | — | — | IA, OO | Delaware | 2024-02-14 | ↗ |
| 8 | Steven Boyd | 3.32M | 9.99% | — | 3.32M | — | — | HC, IN | Delaware | 2024-02-14 | ↗ |
| 9 | CVI Investments, Inc. | 3.13M | 7.10% | — | 3.13M | — | 3.13M | CO | Cayman Islands | 2019-05-02 | ↗ |
| 10 | Heights Capital Management, Inc. | 3.13M | 7.10% | — | 3.13M | — | 3.13M | CO | Delaware | 2019-05-02 | ↗ |
| 11 | Empery Asset Management, LP | 2.93M | 7.05% | — | 2.93M | — | — | PN | Delaware | 2020-02-11 | ↗ |
| 12 | Martin D. Hoe | 2.93M | 7.05% | — | 2.93M | — | — | IN | United States | 2020-02-11 | ↗ |
| 13 | Ryan M. Lane | 2.93M | 7.05% | — | 2.93M | — | — | IN | United States | 2020-02-11 | ↗ |
| 14 | Armistice Capital Master Fund Ltd. | 1.00M | 2.80% | — | 1.00M | — | 1.00M | HC, IN | Delaware | 2019-04-08 | ↗ |
| 15 | Daniel B. Asher | 751.2K | 2.80% | — | 751.2K | — | 751.2K | HC, IN | United States of America | 2018-02-23 | ↗ |
| 16 | Intracoastal Capital LLC | 751.2K | 2.80% | — | 751.2K | — | 751.2K | OO | United States of America | 2018-02-23 | ↗ |
| 17 | Mitchell P. Kopin | 751.2K | 2.80% | — | 751.2K | — | 751.2K | HC, IN | United States of America | 2018-02-23 | ↗ |
| 18 | The Vanguard Group - 23-1945930 | 592.0K | 0.95% | — | 16.0K | 563.8K | 28.2K | IA | Pennsylvania | 2021-02-10 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2025 Q3
Investors holding
24
+2 vs prev Q
New positions
8
Closed positions
6
Increased
13
Reduced
1
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | ADVISOR GROUP HOLDINGS, INC. | — -43.0 (-100.0%) | — -20.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 8 qtrs SOLD |
| 2 | BANK OF AMERICA CORP /DE/ | — -266.0 (-100.0%) | — -141.0 (-100.0%) | 0.00% -0.002 pp | 0.00% +0.000 pp | USD— | 8 qtrs SOLD |
| 3 | BLACKROCK, INC. | — -12.4K (-100.0%) | — -6.6K (-100.0%) | 0.00% -0.080 pp | 0.00% +0.000 pp | USD— | 6 qtrs SOLD |
| 4 | BOGART WEALTH, LLC | — -300.0 (-100.0%) | — -159.0 (-100.0%) | 0.00% -0.002 pp | 0.00% +0.000 pp | USD— | 5 qtrs SOLD |
| 5 | CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | — -12.8K (-100.0%) | — -7.0K (-100.0%) | 0.00% -0.082 pp | 0.00% +0.000 pp | USD— | 4 qtrs SOLD |
| 6 | CVA FAMILY OFFICE, LLC | — -34.0 (-100.0%) | — -18.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 8 qtrs SOLD |
| 7 | ETHOS FINANCIAL GROUP, LLC | — -10.0K (-100.0%) | — -5.3K (-100.0%) | 0.00% -0.065 pp | 0.00% 0.000 pp | USD— | 2 qtrs SOLD |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | — -208.2K (-100.0%) | — -110.4K (-100.0%) | 0.00% -1.341 pp | 0.00% +0.000 pp | USD— | 8 qtrs SOLD |
| 9 | GOLDMAN SACHS GROUP INC | — -12.8K (-100.0%) | — -6.8K (-100.0%) | 0.00% -0.082 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 10 | HRT FINANCIAL LP | — -115.2K (-100.0%) | — -61.0K (-100.0%) | 0.00% -0.742 pp | 0.00% 0.000 pp | USD— | 2 qtrs SOLD |
| 11 | IEQ CAPITAL, LLC | — -36.4K (-100.0%) | — -19.3K (-100.0%) | 0.00% -0.234 pp | 0.00% 0.000 pp | USD— | 2 qtrs SOLD |
| 12 | LPL FINANCIAL LLC | — -58.1K (-100.0%) | — -30.8K (-100.0%) | 0.00% -0.374 pp | 0.00% +0.000 pp | USD— | 7 qtrs SOLD |
| 13 | MOORS & CABOT, INC. | — -10.0K (-100.0%) | — -5.3K (-100.0%) | 0.00% -0.064 pp | 0.00% 0.000 pp | USD— | 2 qtrs SOLD |
| 14 | MORGAN STANLEY | — -926.0 (-100.0%) | — -491.0 (-100.0%) | 0.00% -0.006 pp | 0.00% +0.000 pp | USD— | 8 qtrs SOLD |
| 15 | NBC SECURITIES, INC. | — -14.0 (-100.0%) | — -7.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 16 | NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | — -2.9K (-100.0%) | — -1.5K (-100.0%) | 0.00% -0.019 pp | 0.00% 0.000 pp | USD— | 8 qtrs SOLD |
| 17 | NORTH STAR INVESTMENT MANAGEMENT CORP. | — -17.0 (-100.0%) | — -9.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 8 qtrs SOLD |
| 18 | ROCKEFELLER CAPITAL MANAGEMENT L.P. | — -14.5K (-100.0%) | — -7.7K (-100.0%) | 0.00% -0.093 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 19 | SBI SECURITIES CO., LTD. | — -746.0 (-100.0%) | — -395.0 (-100.0%) | 0.00% -0.005 pp | 0.00% +0.000 pp | USD— | 5 qtrs SOLD |
| 20 | TOWER RESEARCH CAPITAL LLC (TRC) | — -8.4K (-100.0%) | — -4.4K (-100.0%) | 0.00% -0.054 pp | 0.00% 0.000 pp | USD— | 8 qtrs SOLD |
| 21 | TRUIST FINANCIAL CORP | — -10.5K (-100.0%) | — -5.6K (-100.0%) | 0.00% -0.068 pp | 0.00% +0.000 pp | USD— | 6 qtrs SOLD |
| 22 | UBS GROUP AG | — -4.0K (-100.0%) | — -2.1K (-100.0%) | 0.00% -0.026 pp | 0.00% +0.000 pp | USD— | 5 qtrs SOLD |
| 23 | VANGUARD GROUP INC | — -239.9K (-100.0%) | — -127.2K (-100.0%) | 0.00% -1.545 pp | 0.00% +0.000 pp | USD— | 8 qtrs SOLD |
| 24 | WEALTH DIMENSIONS GROUP, LTD. | — -20.0K (-100.0%) | — -10.6K (-100.0%) | 0.00% -0.129 pp | 0.00% -0.002 pp | USD— | 2 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 1 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard Extended Market ETF VXF | 0.00% | 77.1K | 0.05% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
2.33
Bullish
Ratio by volume
3.00
Bullish
Buys
14
Sells
6
Shares acquired
3.79M
Shares disposed
72.3K
Cash buys
—
Cash sales
—
Net activity
+3,715,845
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-12 | Yan Joy | Director | A-Award | A | Stock Options (right to buy) | 150,000 | 0.49 | 73.5K | 164,001 | D | ↗ |
| 2025-11-12 | PICKER DONALD H | Officer | A-Award | A | Performance Based Restricted Stock Units | 200,000 | 0.00 | — | 495,508 | D | ↗ |
| 2025-11-12 | KLEMP WALTER V | Director / Officer | A-Award | A | Stock option (right to buy) | 830,000 | 0.49 | 406.7K | 3,210,731 | D | ↗ |
| 2025-11-12 | George Robert E. | Director | A-Award | A | Stock Options (right to buy) | 150,000 | 0.49 | 73.5K | 165,336 | D | ↗ |
| 2025-11-12 | Foster Jonathan P. | Officer | A-Award | A | Stock option (right to buy) | 600,000 | 0.49 | 294.0K | 1,617,695 | D | ↗ |
| 2025-11-12 | Climaco John M | Director | A-Award | A | Stock Options (right to buy) | 150,000 | 0.49 | 73.5K | 165,169 | D | ↗ |
| 2025-11-12 | Cermak Elizabeth | Director | A-Award | A | Stock Options (right to buy) | 150,000 | 0.49 | 73.5K | 164,668 | D | ↗ |
| 2025-11-12 | CANNON MICHAEL D | Director | A-Award | A | Stock Options (right to buy) | 150,000 | 0.49 | 73.5K | 165,336 | D | ↗ |
| 2025-11-04 | PICKER DONALD H | Officer | M-Exempt | D | Restricted Stock Units | 8,750 | 0.00 | — | 95,508 | D | ↗ |
| 2025-11-04 | KLEMP WALTER V | Director / Officer | M-Exempt | D | Restricted Stock Units | 28,750 | 0.00 | — | 2,380,731 | D | ↗ |
| 2025-11-04 | Foster Jonathan P. | Officer | M-Exempt | D | Restricted Stock Units | 20,625 | 0.00 | — | 1,017,695 | D | ↗ |
| 2025-06-23 | KLEMP WALTER V | Director / Officer | P-Purchase | D | Series E Warrants | 2,027,025 | 0.37 | 750.0K | 2,409,481 | D | ↗ |
| 2025-06-23 | Foster Jonathan P. | Officer | P-Purchase | A | Common Stock | 270,270 | 0.37 | 100.0K | 287,587 | D | ↗ |
| 2025-06-22 | PICKER DONALD H | Officer | F-InKind | D | Common Stock | 430 | 0.27 | 114.81 | 10,152 | D | ↗ |
| 2025-06-22 | KLEMP WALTER V | Director / Officer | M-Exempt | D | Restricted Stock Units | 8,990 | 0.00 | — | 382,456 | D | ↗ |
| 2025-06-22 | Foster Jonathan P. | Officer | M-Exempt | A | Common Stock | 4,328 | 0.00 | — | 18,371 | D | ↗ |
| 2025-06-20 | PICKER DONALD H | Officer | M-Exempt | D | Restricted Stock Units | 1,078 | 0.00 | — | 106,024 | D | ↗ |
| 2025-06-20 | KLEMP WALTER V | Director / Officer | F-InKind | D | Common Stock | 914 | 0.27 | 244.04 | 61,132 | D | ↗ |
| 2025-06-20 | Foster Jonathan P. | Officer | M-Exempt | D | Restricted Stock Units | 2,711 | 0.00 | — | 231,838 | D | ↗ |
| 2025-06-16 | KLEMP WALTER V | Director / Officer | M-Exempt | A | Common Stock | 1,667 | 0.00 | — | 58,702 | D | ↗ |
| 2025-06-16 | Foster Jonathan P. | Officer | F-InKind | D | Common Stock | 203 | 0.69 | 139.10 | 11,993 | D | ↗ |
| 2024-11-04 | Yan Joy | Director | A-Award | A | Stock option (right to buy) | 10,000 | 2.45 | 24.5K | 14,001 | D | ↗ |
| 2024-11-04 | PICKER DONALD H | Officer | A-Award | A | Restricted Stock Units | 35,000 | 0.00 | — | 101,358 | D | ↗ |
| 2024-11-04 | KLEMP WALTER V | Director / Officer | A-Award | A | Stock option (right to buy) | 100,000 | 2.45 | 245.0K | 213,152 | D | ↗ |
| 2024-11-04 | George Robert E. | Director | A-Award | A | Stock option (right to buy) | 10,000 | 2.45 | 24.5K | 15,336 | D | ↗ |
| 2024-11-04 | Foster Jonathan P. | Officer | A-Award | A | Restricted Stock Units | 82,500 | 0.00 | — | 212,337 | D | ↗ |
| 2024-11-04 | Climaco John M | Director | A-Award | A | Stock option (right to buy) | 10,000 | 2.45 | 24.5K | 15,169 | D | ↗ |
| 2024-11-04 | Cermak Elizabeth | Director | A-Award | A | Stock option (right to buy) | 10,000 | 2.45 | 24.5K | 14,668 | D | ↗ |
| 2024-11-04 | CANNON MICHAEL D | Director | A-Award | A | Stock option (right to buy) | 10,000 | 2.45 | 24.5K | 15,336 | D | ↗ |
| 2024-10-25 | PICKER DONALD H | Officer | A-Award | A | Performance Based Restricted Stock Units | 5,744 | 0.00 | — | 107,102 | D | ↗ |
| 2024-10-25 | KLEMP WALTER V | Director / Officer | A-Award | A | Performance Based Restricted Stock Units | 43,590 | 0.00 | — | 371,742 | D | ↗ |
| 2024-10-25 | Foster Jonathan P. | Officer | A-Award | A | Performance Based Restricted Stock Units | 19,180 | 0.00 | — | 231,517 | D | ↗ |
| 2024-07-02 | KLEMP WALTER V | Director / Officer | M-Exempt | D | Restricted Stock Units | 982 | 0.00 | — | 113,152 | — | ↗ |
| 2024-06-22 | PICKER DONALD H | Officer | F-InKind | A | Common Stock | 524 | 3.74 | 2.0K | 8,001 | — | ↗ |
| 2024-06-22 | KLEMP WALTER V | Director / Officer | F-InKind | D | Common Stock | 2,190 | 3.74 | 8.2K | 56,293 | — | ↗ |
| 2024-06-22 | Foster Jonathan P. | Officer | M-Exempt | A | Common Stock | 4,329 | 0.00 | — | 12,416 | — | ↗ |
| 2024-06-20 | PICKER DONALD H | Officer | M-Exempt | D | Restricted Stock Units | 1,078 | 0.00 | — | 28,124 | — | ↗ |
| 2024-06-20 | KLEMP WALTER V | Director / Officer | M-Exempt | D | Restricted Stock Units | 3,750 | 0.00 | — | 123,124 | — | ↗ |
| 2024-06-20 | Foster Jonathan P. | Officer | M-Exempt | D | Restricted Stock Units | 2,712 | 0.00 | — | 69,166 | — | ↗ |
| 2024-06-16 | KLEMP WALTER V | Director / Officer | M-Exempt | D | Restricted Stock Units | 1,667 | 0.00 | — | 126,874 | — | ↗ |
| 2024-06-16 | Foster Jonathan P. | Officer | M-Exempt | A | Common Stock | 834 | 0.00 | — | 6,207 | — | ↗ |
| 2023-12-26 | KLEMP WALTER V | Director / Officer | P-Purchase | A | Common Stock | 188,404 | 0.69 | 130.0K | 680,880 | — | ↗ |
| 2023-12-26 | George Robert E. | Director | P-Purchase | A | Common Stock | 14,493 | 0.69 | 10.0K | 14,660 | — | ↗ |
| 2023-12-26 | Foster Jonathan P. | Officer | P-Purchase | A | Common Stock | 28,986 | 0.69 | 20.0K | 80,556 | — | ↗ |
| 2023-07-11 | KLEMP WALTER V | Director / Officer | M-Exempt | D | Restricted Stock Units | 13,204 | 0.00 | — | 1,928,145 | — | ↗ |
| 2023-07-02 | KLEMP WALTER V | Director / Officer | M-Exempt | A | Common Stock | 14,717 | 0.00 | — | 486,072 | — | ↗ |
| 2023-06-22 | PICKER DONALD H | Officer | A-Award | A | Restricted Stock Units | 105,938 | 0.00 | — | 437,948 | — | ↗ |
| 2023-06-22 | KLEMP WALTER V | Director / Officer | A-Award | A | Restricted Stock Units | 539,375 | 0.00 | — | 1,956,066 | — | ↗ |
| 2023-06-22 | Foster Jonathan P. | Officer | A-Award | A | Restricted Stock Units | 259,688 | 0.00 | — | 1,090,626 | — | ↗ |
| 2023-06-20 | PICKER DONALD H | Officer | M-Exempt | A | Common Stock | 16,167 | 0.00 | — | 94,273 | — | ↗ |
| 2023-06-20 | KLEMP WALTER V | Director / Officer | F-InKind | D | Common Stock | 13,697 | 0.57 | 7.8K | 471,355 | — | ↗ |
| 2023-06-20 | Foster Jonathan P. | Officer | M-Exempt | A | Common Stock | 40,667 | 0.00 | — | 61,246 | — | ↗ |
| 2023-06-16 | KLEMP WALTER V | Director / Officer | M-Exempt | A | Common Stock | 25,000 | 0.00 | — | 434,890 | — | ↗ |
| 2023-06-16 | Foster Jonathan P. | Officer | M-Exempt | D | Restricted Stock Units | 12,500 | 0.00 | — | 721,605 | — | ↗ |
| 2023-05-25 | Yan Joy | Director | A-Award | A | Stock option (right to buy) | 15,000 | 0.62 | 9.3K | 60,000 | — | ↗ |
| 2023-05-25 | George Robert E. | Director | A-Award | A | Stock option (right to buy) | 15,000 | 0.62 | 9.3K | 80,001 | — | ↗ |
| 2023-05-25 | Climaco John M | Director | A-Award | A | Stock option (right to buy) | 15,000 | 0.62 | 9.3K | 77,501 | — | ↗ |
| 2023-05-25 | Cermak Elizabeth | Director | A-Award | A | Stock option (right to buy) | 15,000 | 0.62 | 9.3K | 70,000 | — | ↗ |
| 2023-05-25 | CANNON MICHAEL D | Director | A-Award | A | Stock option (right to buy) | 15,000 | 0.62 | 9.3K | 80,001 | — | ↗ |
| 2022-11-25 | KLEMP WALTER V | Officer | P-Purchase | A | Common Stock | 45,000 | 1.28 | 57.6K | 409,890 | — | ↗ |
| 2022-11-21 | KLEMP WALTER V | Officer | P-Purchase | A | Common Stock | 22,500 | 1.15 | 25.9K | 364,890 | — | ↗ |
| 2022-11-17 | KLEMP WALTER V | Officer | P-Purchase | A | Common Stock | 24,742 | 1.02 | 25.3K | 342,390 | — | ↗ |
| 2022-11-16 | KLEMP WALTER V | Officer | P-Purchase | A | Common Stock | 85,213 | 0.97 | 82.6K | 317,648 | — | ↗ |
| 2022-07-11 | KLEMP WALTER V | Director / Officer | M-Exempt | D | Restricted Stock Units | 13,205 | 0.00 | — | 1,097,941 | D | ↗ |
| 2022-07-02 | KLEMP WALTER V | Director / Officer | M-Exempt | A | Common Stock | 14,717 | 0.00 | — | 226,030 | D | ↗ |
| 2022-06-20 | Yan Joy | Director | A-Award | A | Stock option (right to buy) | 15,000 | 0.00 | — | 45,000 | — | ↗ |
| 2022-06-20 | PICKER DONALD H | Officer | A-Award | A | Stock option (right to buy) | 65,000 | 1.49 | 96.9K | 183,510 | — | ↗ |
| 2022-06-20 | KLEMP WALTER V | Officer | A-Award | A | Stock option (right to buy) | 360,000 | 0.00 | — | 1,035,862 | — | ↗ |
| 2022-06-20 | George Robert E. | Director | A-Award | A | Stock option (right to buy) | 23,333 | 1.49 | 34.8K | 50,001 | — | ↗ |
| 2022-06-20 | Foster Jonathan P. | Officer | A-Award | A | Stock option (right to buy) | 155,000 | 0.00 | — | 571,438 | — | ↗ |
| 2022-06-20 | Climaco John M | Director | A-Award | A | Stock option (right to buy) | 23,333 | 0.00 | — | 47,501 | — | ↗ |
| 2022-06-20 | Cermak Elizabeth | Director | A-Award | A | Stock option (right to buy) | 23,333 | 1.49 | 34.8K | 40,000 | — | ↗ |
| 2022-06-20 | CANNON MICHAEL D | Director | A-Award | A | Stock option (right to buy) | 23,333 | 0.00 | — | 50,001 | — | ↗ |
| 2022-06-16 | KLEMP WALTER V | Officer | F-InKind | D | Common Stock | 6,088 | 1.33 | 8.1K | 211,313 | — | ↗ |
| 2022-06-16 | Foster Jonathan P. | Officer | M-Exempt | A | Common Stock | 12,500 | 0.00 | — | 14,167 | — | ↗ |
| 2022-03-01 | Yan Joy | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-07-11 | KLEMP WALTER V | Director / Officer | M-Exempt | D | Restricted Stock Units | 13,205 | 0.00 | — | 700,862 | — | ↗ |
| 2021-07-02 | KLEMP WALTER V | Director / Officer | M-Exempt | D | Restricted Stock Units | 14,718 | 0.00 | — | 717,651 | — | ↗ |
| 2021-06-16 | PICKER DONALD H | Officer | A-Award | A | Stock option (right to buy) | 62,676 | 3.73 | 233.8K | 118,510 | — | ↗ |
| 2021-06-16 | KLEMP WALTER V | Director / Officer | A-Award | A | Restricted Stock Units | 100,000 | 0.00 | — | 728,785 | — | ↗ |
| 2021-06-16 | Foster Jonathan P. | Officer | A-Award | A | Stock option (right to buy) | 108,770 | 3.73 | 405.7K | 378,938 | — | ↗ |
| 2021-06-07 | George Robert E. | Director | A-Award | A | Stock option (right to buy) | 10,000 | 3.95 | 39.5K | 26,668 | — | ↗ |
| 2021-06-07 | Climaco John M | Director | A-Award | A | Stock option (right to buy) | 10,000 | 3.95 | 39.5K | 24,168 | — | ↗ |
| 2021-06-07 | Cermak Elizabeth | Director | A-Award | A | Stock option (right to buy) | 10,000 | 3.95 | 39.5K | 16,667 | — | ↗ |
| 2021-06-07 | CANNON MICHAEL D | Director | A-Award | A | Stock option (right to buy) | 10,000 | 3.95 | 39.5K | 26,668 | — | ↗ |
| 2020-10-02 | Cermak Elizabeth | Director | A-Award | A | Stock option (right to buy) | 40,000 | 0.81 | 32.3K | 40,000 | — | ↗ |
| 2020-08-20 | Priebe Waldemar | 10% Owner | A-Award | A | Stock option (right to buy) | 100,000 | 0.96 | 96.0K | 100,000 | — | ↗ |
| 2020-07-13 | KLEMP WALTER V | Director / Officer | M-Exempt | D | Restricted Stock Units | 79,227 | 0.00 | — | 2,430,891 | — | ↗ |
| 2020-07-02 | PICKER DONALD H | Officer | A-Award | A | Stock option (right to buy) | 100,000 | 0.93 | 92.8K | 335,000 | — | ↗ |
| 2020-07-02 | KLEMP WALTER V | Director / Officer | A-Award | A | Stock option (right to buy) | 500,000 | 0.93 | 464.0K | 2,156,907 | — | ↗ |
| 2020-07-02 | Foster Jonathan P. | Officer | A-Award | A | Stock option (right to buy) | 460,000 | 0.93 | 426.9K | 1,621,000 | — | ↗ |
| 2020-06-15 | George Robert E. | Director | A-Award | A | Stock option (right to buy) | 15,000 | 1.12 | 16.8K | 100,000 | — | ↗ |
| 2020-06-15 | Climaco John M | Director | A-Award | A | Stock option (right to buy) | 15,000 | 1.12 | 16.8K | 85,000 | — | ↗ |
| 2020-06-15 | CANNON MICHAEL D | Director | A-Award | A | Stock option (right to buy) | 15,000 | 1.12 | 16.8K | 100,000 | — | ↗ |
| 2019-07-11 | PICKER DONALD H | Officer | A-Award | A | Stock option (right to buy) | 100,000 | 1.31 | 131.0K | 235,000 | — | ↗ |
| 2019-07-11 | KLEMP WALTER V | Director / Officer | A-Award | A | Stock option (right to buy) | 500,000 | 1.31 | 655.0K | 1,340,000 | — | ↗ |
| 2019-07-11 | George Robert E. | Director | A-Award | A | Stock option (right to buy) | 35,000 | 1.31 | 45.9K | 120,000 | — | ↗ |
| 2019-07-11 | Foster Jonathan P. | Officer | A-Award | A | Stock option (right to buy) | 315,000 | 1.31 | 412.7K | 1,161,000 | — | ↗ |
| 2019-07-11 | Climaco John M | Director | A-Award | A | Stock option (right to buy) | 35,000 | 1.31 | 45.9K | 105,000 | — | ↗ |
| 2019-07-11 | CANNON MICHAEL D | Director | A-Award | A | Stock option (right to buy) | 35,000 | 1.31 | 45.9K | 120,000 | — | ↗ |
| 2019-05-22 | George Robert E. | Director | A-Award | A | Stock option (right to buy) | 15,000 | 1.15 | 17.3K | 85,000 | — | ↗ |
| 2019-05-22 | Climaco John M | Director | A-Award | A | Stock option (right to buy) | 15,000 | 1.15 | 17.3K | 70,000 | — | ↗ |
| 2019-05-22 | CANNON MICHAEL D | Director | A-Award | A | Stock option (right to buy) | 15,000 | 1.15 | 17.3K | 85,000 | — | ↗ |
| 2018-06-06 | PICKER DONALD H | Officer | A-Award | A | Stock option (right to buy) | 75,000 | 1.82 | 136.5K | 135,000 | — | ↗ |
| 2018-06-06 | KLEMP WALTER V | Director / Officer | A-Award | A | Stock option (right to buy) | 500,000 | 1.82 | 910.0K | 840,000 | — | ↗ |
| 2018-06-06 | George Robert E. | Director | A-Award | A | Stock option (right to buy) | 35,000 | 1.82 | 63.7K | 70,000 | — | ↗ |
| 2018-06-06 | Foster Jonathan P. | Officer | A-Award | A | Stock option (right to buy) | 301,000 | 1.82 | 547.8K | 846,000 | — | ↗ |
| 2018-06-06 | Climaco John M | Director | A-Award | A | Stock option (right to buy) | 35,000 | 1.82 | 63.7K | 55,000 | — | ↗ |
| 2018-06-06 | CANNON MICHAEL D | Director | A-Award | A | Stock option (right to buy) | 35,000 | 1.82 | 63.7K | 70,000 | — | ↗ |
| 2017-10-03 | PICKER DONALD H | Officer | A-Award | A | Stock option (right to buy) | 60,000 | 2.49 | 149.4K | 60,000 | — | ↗ |
| 2017-10-03 | KLEMP WALTER V | Director / Officer / 10% Owner | A-Award | A | Stock option (right to buy) | 340,000 | 2.49 | 846.6K | 340,000 | — | ↗ |
| 2017-10-03 | Foster Jonathan P. | Officer | A-Award | A | Stock option (right to buy) | 145,000 | 2.49 | 361.1K | 545,000 | — | ↗ |
| 2017-08-16 | Priebe Waldemar | 10% Owner | S-Sale | D | Common Stock | 100,000 | 1.70 | 170.3K | 2,781,573 | — | ↗ |
| 2017-08-16 | KLEMP WALTER V | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 100,000 | 1.70 | 170.3K | 967,724 | — | ↗ |
| 2017-07-24 | George Robert E. | Director | A-Award | A | Option to purchase common stock | 15,000 | 1.87 | 28.1K | 35,000 | — | ↗ |
| 2017-07-24 | Climaco John M | Director | A-Award | A | Option to purchase common stock | 20,000 | 1.87 | 37.4K | 20,000 | — | ↗ |
| 2017-07-24 | CANNON MICHAEL D | Director | A-Award | A | Option to purchase common stock | 15,000 | 1.87 | 28.1K | 35,000 | — | ↗ |
| 2017-05-11 | KLEMP WALTER V | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 12,000 | 0.81 | 9.7K | 1,067,724 | — | ↗ |
| 2017-05-05 | Northcut Jacqueline | Director | P-Purchase | A | Common Stock | 1,000 | 0.82 | 820.00 | 1,000 | — | ↗ |
| 2017-04-28 | George Robert E. | Director | P-Purchase | A | Common Stock | 1,000 | 0.94 | 938.40 | 1,000 | — | ↗ |
| 2017-04-25 | Foster Jonathan P. | Officer | P-Purchase | A | Common Stock | 10,000 | 0.86 | 8.6K | 10,000 | — | ↗ |
| 2016-09-23 | Northcut Jacqueline | Director | A-Award | A | Option to purchase common stock | 20,000 | 5.71 | 114.2K | 20,000 | — | ↗ |
| 2016-09-23 | George Robert E. | Director | A-Award | A | Option to purchase common stock | 20,000 | 5.71 | 114.2K | 20,000 | — | ↗ |
| 2016-09-23 | CANNON MICHAEL D | Director | A-Award | A | Option to purchase common stock | 20,000 | 5.71 | 114.2K | 20,000 | — | ↗ |
| 2016-08-19 | Foster Jonathan P. | Officer | A-Award | A | Option to purchase common stock | 400,000 | 5.85 | 2.34M | 400,000 | — | ↗ |
| 2016-06-02 | Priebe Waldemar | 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 388,000 | — | ↗ |
| 2016-06-02 | PLOTH LOUIS JR | Officer | — | D | Option to purchase common stock | 200,000 | 0.20 | 40.0K | 0 | — | ↗ |
| 2016-06-02 | PICKER DONALD H | Officer / 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 99,000 | — | ↗ |
| 2016-06-02 | Northcut Jacqueline | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2016-06-02 | KLEMP WALTER V | Director / Officer / 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 1,075,000 | — | ↗ |
| 2016-06-02 | George Robert E. | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2016-06-02 | CANNON MICHAEL D | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2010-01-27 | MPM BIOVENTURES II QP LP | 10% Owner | D-Return | D | Common Stock | 4,814,725 | 0.05 | 220.2K | 0 | — | ↗ |
| 2010-01-27 | EVNIN LUKE | Director / 10% Owner | D-Return | D | Common Stock | 4,814,725 | 0.05 | 220.2K | 0 | — | ↗ |
| 2009-06-23 | Stoner Elizabeth | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 0.41 | 4.1K | 10,000 | — | ↗ |
| 2009-06-23 | ORONSKY ARNOLD L | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 0.41 | 4.1K | 10,000 | — | ↗ |
| 2009-06-23 | EVNIN LUKE | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 10,000 | 0.41 | 4.1K | 10,000 | — | ↗ |
| 2009-06-23 | BURGESS DANIEL D | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 0.41 | 4.1K | 10,000 | — | ↗ |
| 2009-01-29 | Millican Trisha | Officer | D-Return | D | Stock Option (Right to Buy) | 4,515 | 2.46 | 11.1K | 0 | — | ↗ |
| 2009-01-29 | Baracchini Edgardo Jr | Officer | D-Return | D | Stock Option (Right to Buy) | 4,368 | 6.88 | 30.1K | 0 | — | ↗ |
| 2008-12-11 | Stoner Elizabeth | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 0.45 | 4.5K | 10,000 | — | ↗ |
| 2008-09-26 | Millican Trisha | Officer | A-Award | A | Stock Option (Right to Buy) | 6,690 | 1.13 | 7.6K | 6,690 | — | ↗ |
| 2008-08-04 | Millican Trisha | Officer | A-Award | A | Stock Option (Right to Buy) | 29,826 | 1.46 | 43.5K | 29,826 | — | ↗ |
| 2008-08-04 | Baracchini Edgardo Jr | Officer | A-Award | A | Stock Option (Right to Buy) | 100,000 | 1.46 | 146.0K | 100,000 | — | ↗ |
| 2008-06-10 | ORONSKY ARNOLD L | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 10,000 | 1.79 | 17.9K | 10,000 | — | ↗ |
| 2008-06-10 | EVNIN LUKE | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 10,000 | 1.79 | 17.9K | 10,000 | — | ↗ |
| 2008-06-10 | BURGESS DANIEL D | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 1.79 | 17.9K | 10,000 | — | ↗ |
| 2008-05-09 | Millican Trisha | Officer | — | D | Common Stock | 0 | 0.00 | — | 1,151 | — | ↗ |
| 2008-04-23 | Stoner Elizabeth | Director | A-Award | A | Stock Option (Right to Buy) | 20,000 | 2.41 | 48.2K | 20,000 | — | ↗ |
| 2008-04-16 | ORONSKY ARNOLD L | Director / 10% Owner | X-InTheMoney | A | Common Stock | 6,824 | 2.34 | 16.0K | 177,970 | — | ↗ |
| 2008-04-16 | MPM BIOVENTURES II QP LP | 10% Owner | J-Other | A | Common Stock Warrant (Right to Buy) | 244,881 | 2.34 | 573.0K | 244,881 | — | ↗ |
| 2008-04-16 | INTERWEST PARTNERS VII L P | 10% Owner | H-ExpireLong | D | Common Stock Warrant (Right to Buy) | 5,687 | 8.69 | 49.4K | 0 | — | ↗ |
| 2008-04-16 | EVNIN LUKE | Director / 10% Owner | P-Purchase | A | Common Stock | 71,866 | 2.34 | 168.2K | 4,814,725 | — | ↗ |
| 2008-04-16 | CREDIT SUISSE/ | 10% Owner | P-Purchase | A | Common Stock | 196,633 | 2.34 | 460.1K | 3,863,422 | — | ↗ |
| 2008-04-02 | Baracchini Edgardo Jr | Officer | A-Award | A | Stock Option (Right to Buy) | 75,000 | 2.10 | 157.5K | 75,000 | — | ↗ |
| 2007-06-01 | ORONSKY ARNOLD L | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 8.04 | 80.4K | 10,000 | — | ↗ |
| 2007-06-01 | EVNIN LUKE | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 8.04 | 80.4K | 10,000 | — | ↗ |
| 2007-06-01 | BURGESS DANIEL D | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 8.04 | 80.4K | 10,000 | — | ↗ |
| 2007-04-24 | Baracchini Edgardo Jr | Officer | S-Sale | D | Common Stock | 2,500 | 8.18 | 20.5K | 4,812 | — | ↗ |
| 2007-03-07 | Baracchini Edgardo Jr | Officer | A-Award | A | Stock Option (Right to Buy) | 60,000 | 7.60 | 456.0K | 60,000 | — | ↗ |
| 2007-02-26 | Baracchini Edgardo Jr | Officer | S-Sale | D | Common Stock | 700 | 8.00 | 5.6K | 7,312 | — | ↗ |
| 2006-11-03 | CREDIT SUISSE/ | 10% Owner | P-Purchase | A | Common Stock | 527,000 | 7.17 | 3.78M | 3,547,335 | — | ↗ |
| 2006-11-01 | CREDIT SUISSE/ | 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 3,020,335 | — | ↗ |
| 2006-06-26 | Baracchini Edgardo Jr | Officer | S-Sale | D | Common Stock | 250 | 8.35 | 2.1K | 892 | — | ↗ |
| 2006-05-22 | CASH HARVEY B | 10% Owner | P-Purchase | A | Common Stock | 39,836 | 8.02 | 319.6K | 50,000 | — | ↗ |
| 2006-05-19 | CASH HARVEY B | 10% Owner | P-Purchase | A | Common Stock | 5,000 | 8.10 | 40.5K | 10,164 | — | ↗ |
| 2006-05-18 | CASH HARVEY B | 10% Owner | P-Purchase | A | Common Stock | 700 | 8.10 | 5.7K | 5,164 | — | ↗ |
| 2006-05-16 | CASH HARVEY B | 10% Owner | P-Purchase | A | Common Stock | 4,464 | 8.00 | 35.7K | 4,464 | — | ↗ |
| 2006-05-09 | ORONSKY ARNOLD L | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 8.51 | 85.1K | 10,000 | — | ↗ |
| 2006-05-09 | EVNIN LUKE | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 8.51 | 85.1K | 10,000 | — | ↗ |
| 2006-05-09 | BURGESS DANIEL D | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 8.51 | 85.1K | 10,000 | — | ↗ |
| 2006-03-19 | Baracchini Edgardo Jr | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 37,300 | 9.03 | 336.8K | 37,300 | — | ↗ |
| 2005-12-09 | Baracchini Edgardo Jr | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 4,368 | 6.88 | 30.1K | 4,368 | — | ↗ |
| 2005-09-30 | ORONSKY ARNOLD L | Director / 10% Owner | P-Purchase | A | Common Stock Warrant (right to buy) | 6,824 | 6.74 | 46.0K | 6,824 | — | ↗ |
| 2005-09-30 | MPM BIOVENTURES II QP LP | 10% Owner | P-Purchase | A | Common Stock Warrant (Right to Buy) | 244,881 | 6.74 | 1.65M | 244,881 | — | ↗ |
| 2005-09-30 | INTERWEST PARTNERS VII L P | 10% Owner | P-Purchase | A | Common Stock Warrant (right to buy) | 6,824 | 6.74 | 46.0K | 6,824 | — | ↗ |
| 2005-09-30 | EVNIN LUKE | Director / 10% Owner | P-Purchase | D | Common Stock | 699,659 | 5.86 | 4.10M | 4,497,978 | — | ↗ |
| 2005-09-30 | CREDIT SUISSE/ | 10% Owner | P-Purchase | A | Warrants (right to buy Common Stock) | 119,454 | 6.74 | 805.1K | 368,345 | — | ↗ |
| 2005-05-18 | ORONSKY ARNOLD L | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 10,000 | 2.65 | 26.5K | 10,000 | — | ↗ |
| 2005-05-18 | EVNIN LUKE | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 10,000 | 2.65 | 26.5K | 10,000 | — | ↗ |
| 2005-05-18 | Baracchini Edgardo Jr | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 13,653 | 2.65 | 36.2K | 13,653 | — | ↗ |
| 2005-05-18 | BURGESS DANIEL D | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 2.65 | 26.5K | 10,000 | — | ↗ |
| 2005-01-03 | ORONSKY ARNOLD L | Director / 10% Owner | G-Gift | D | Common Stock | 500 | 0.00 | — | 0 | — | ↗ |
| 2004-12-22 | ORONSKY ARNOLD L | Director / 10% Owner | P-Purchase | A | Common Stock | 500 | 6.84 | 3.4K | 500 | — | ↗ |
| 2004-06-21 | ORONSKY ARNOLD L | Director / 10% Owner | C-Conversion | D | Series E Preferred Convertible Stock | 31,464 | 0.00 | — | 0 | — | ↗ |
| 2004-06-21 | MPM BIOVENTURES II QP LP | 10% Owner | P-Purchase | A | Common Stock | 357,000 | 7.00 | 2.50M | 3,798,319 | — | ↗ |
| 2004-06-21 | INTERWEST PARTNERS VII L P | 10% Owner | C-Conversion | D | Series C Convertible Preferred Stock | 37,468 | 0.00 | — | 0 | — | ↗ |
| 2004-06-21 | EVNIN LUKE | Director / 10% Owner | C-Conversion | A | Common Stock | 1,139,599 | 0.00 | — | 3,441,319 | — | ↗ |
| 2004-06-21 | CREDIT SUISSE FIRST BOSTON/ | 10% Owner | C-Conversion | A | Common Stock | 514,401 | 0.00 | — | 514,404 | — | ↗ |
| 2004-06-21 | BURGESS DANIEL D | Director | A-Award | A | Stock Option (Right to Buy) | 13,416 | 6.50 | 87.2K | 13,416 | — | ↗ |
| 2004-06-15 | ORONSKY ARNOLD L | Director / 10% Owner | — | I | Series D Convertible Preferred Stock | 25,850 | 0.00 | — | 0 | — | ↗ |
| 2004-06-15 | MPM BIOVENTURES III QP LP | 10% Owner | — | I | Series D Convertible Preferred Stock | 5,737,704 | 0.00 | — | 0 | — | ↗ |
| 2004-06-15 | MPM BIOVENTURES II QP LP | 10% Owner | — | I | Warrant to Purchase Series D Convertible Preferred Stock | 1,262,295 | 1.50 | 1.89M | 0 | — | ↗ |
| 2004-06-15 | EVNIN LUKE | Director / 10% Owner | — | I | Series C Convertible Preferred Stock | 7,969,230 | 0.00 | — | 0 | — | ↗ |
| 2004-06-15 | CREDIT SUISSE FIRST BOSTON/ | 10% Owner | — | I | Series E Convertible Preferred Stock | 22,123 | 0.00 | — | 0 | — | ↗ |
| 2004-06-15 | Baracchini Edgardo Jr | Officer | — | I | Common Stock | 0 | 0.00 | — | 33,521 | — | ↗ |
| 2004-06-15 | BURGESS DANIEL D | Director | — | D | Stock Option (Right to Buy) | 6,584 | 1.46 | 9.6K | 0 | — | ↗ |
Executive team
Top executives
Shares Outstanding
1.21M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2024 | Walter V. Klemp, Chairman, President - Chief Executive Officer | 565.0K | — | 281.8K | 197.5K | 375.0K | 39.5K | 1.46M | 32.85% | ↗ |
| 2 | 2024 | Jonathan P. Foster, Executive Vice President and Chief Financial Officer | 405.0K | — | 202.1K | 128.4K | 200.0K | 54.2K | 989.6K | 33.39% | ↗ |
| 3 | 2024 | Donald Picker, Chief Scientific Officer | 340.0K | — | 85.8K | 79.0K | 160.0K | 29.3K | 694.1K | 23.74% | ↗ |
| 4 | 2023 | Walter V. Klemp, Chairman, President - Chief Executive Officer | 565.0K | — | 323.6K | 196.4K | 292.5K | 37.0K | 1.41M | 36.76% | ↗ |
| 5 | 2023 | Jonathan P. Foster, Executive Vice President and Chief Financial Officer | 405.0K | — | 155.8K | 73.7K | 156.0K | 50.2K | 840.6K | 27.30% | ↗ |
| 6 | 2023 | Donald Picker, Chief Scientific Officer | 340.0K | — | 63.6K | 49.1K | 124.8K | 21.6K | 599.1K | 18.81% | ↗ |
| 7 | 2022 | Walter V. Klemp, Chairman, President - Chief Executive Officer | 565.0K | — | 335.3K | 284.8K | 750.0K | 36.0K | 1.97M | 31.46% | ↗ |
| 8 | 2022 | Jonathan P. Foster, Executive Vice President and Chief Financial Officer | 405.0K | — | 242.4K | 196.2K | 200.0K | 48.7K | 1.09M | 40.15% | ↗ |
| 9 | 2022 | Donald Picker, Chief Scientific Officer | 340.0K | — | 96.4K | 82.3K | 160.0K | 20.8K | 699.5K | 25.54% | ↗ |
| 10 | 2021 | Walter V. Klemp, Chairman, President - Chief Executive Officer | 537.9K | — | 373.0K | 722.7K | 317.7K | 36.0K | 1.99M | 55.13% | ↗ |
| 11 | 2021 | Jonathan P. Foster, Executive Vice President and Chief Financial Officer | 392.5K | — | 186.5K | 351.5K | 170.1K | 48.6K | 1.15M | 46.81% | ↗ |
| 12 | 2021 | Donald Picker, Chief Scientific Officer | 323.3K | — | — | 202.5K | 136.0K | 20.5K | 682.4K | 29.68% | ↗ |
| 13 | 2020 | Walter V. Klemp, Chairman, President - Chief Executive Officer | 500.0K | — | 327.8K | — | 242.5K | 35.6K | 1.52M | 21.61% | ↗ |
| 14 | 2020 | Jonathan P. Foster, Executive Vice President and Chief Financial Officer | 375.0K | — | — | — | 145.5K | 48.1K | 946.6K | 0.00% | ↗ |
| 15 | 2020 | Donald Picker, Chief Scientific Officer | 300.0K | — | — | — | 117.9K | 20.3K | 520.3K | 0.00% | ↗ |
| 16 | 2019 | Walter V. Klemp, Chairman, President - Chief Executive Officer | 625.0K | — | 415.1K | — | 215.4K | 21.2K | 1.80M | 23.04% | ↗ |
| 17 | 2019 | Jonathan P. Foster, Executive Vice President and Chief Financial Officer | 360.4K | — | — | — | 121.0K | 26.7K | 838.9K | 0.00% | ↗ |
| 18 | 2019 | Donald Picker, Chief Scientific Officer | 289.6K | — | — | — | 100.1K | 27.5K | 522.2K | 0.00% | ↗ |
| 19 | 2018 | Walter V. Klemp, Chairman, President - Chief Executive Officer | 402.5K | — | — | 777.9K | 138.3K | 27.1K | 1.35M | 57.81% | ↗ |
| 20 | 2018 | Jonathan P. Foster, Executive Vice President and Chief Financial Officer | 323.3K | — | — | 388.3K | 104.5K | 29.6K | 845.7K | 45.91% | ↗ |
| 21 | 2018 | Donald Picker, Chief Scientific Officer | 254.2K | — | — | 96.8K | 54.5K | 34.0K | 439.4K | 22.02% | ↗ |
| 22 | 2018 | Summary Compensation Table - 2018 Name and Principal Position | 2.0K | 2.0K | — | 2.0K | — | 2.0K | 2.0K | 100.00% | ↗ |
| 23 | 2018 | Jonathan P. Foster, Chief Financial Officer and Executive Vice President | — | — | — | — | — | — | — | — | ↗ |
| 24 | 2017 | Summary Compensation Table - 2017 Name and Principal Position | 2.0K | 2.0K | — | 2.0K | — | 2.0K | 2.0K | 100.00% | ↗ |
| 25 | 2017 | Walter V. Klemp, Chairman, President - Chief Executive Officer | — | — | — | — | — | — | — | — | ↗ |
| 26 | 2017 | Donald Picker, Chief Scientific Officer | — | — | — | — | — | — | — | — | ↗ |
| 27 | 2017 | Jonathan P. Foster, Chief Financial Officer and Executive Vice President | — | — | — | — | — | — | — | — | ↗ |
| 28 | 2017 | Walter V. Klemp, Chairman, President Chief Executive Officer | — | — | — | — | — | — | — | — | ↗ |
| 29 | 2017 | Jonathan P. Foster, Chief Financial Officer | — | — | — | — | — | — | — | — | ↗ |
| 30 | 2016 | Jonathan P. Foster, Chief Financial Officer and Executive Vice President | 97.7K | — | — | 1.51M | — | 7.2K | 1.61M | 93.49% | ↗ |
| 31 | 2016 | Walter V. Klemp, Chairman and Chief Executive Officer | 175.0K | — | — | — | — | — | 175.0K | 0.00% | ↗ |
| 32 | 2016 | Donald Picker, President and Chief Operating Officer | 131.3K | — | — | — | — | — | 131.3K | 0.00% | ↗ |
| 33 | 2016 | Louis Ploth, Jr., Former Chief Financial Officer | 111.0K | — | — | — | — | 7.5K | 118.5K | 0.00% | ↗ |
| 34 | 2016 | Donald Picker, Chief Scientific Officer | — | — | — | — | — | — | — | — | ↗ |
| 35 | 2016 | Walter V. Klemp, Chairman, President Chief Executive Officer | — | — | — | — | — | — | — | — | ↗ |
| 36 | 2016 | Jonathan P. Foster, Chief Financial Officer | — | — | — | — | — | — | — | — | ↗ |
| 37 | 2016 | Walter V. Klemp, Chairman and Acting Chief Executive Officer | — | — | — | — | — | — | — | — | ↗ |
| 38 | 2015 | Louis Ploth, Jr., Former Chief Financial Officer | 44.1K | — | — | 27.4K | — | — | 71.5K | 38.29% | ↗ |
| 39 | 2015 | Walter V. Klemp, Chairman and Acting Chief Executive Officer | 40.7K | — | — | — | — | — | 40.7K | 0.00% | ↗ |
| 40 | 2015 | Donald Picker, President and Chief Operating Officer | — | — | — | — | — | — | — | — | ↗ |
| 41 | 2015 | Walter V. Klemp, Chairman and Chief Executive Officer | — | — | — | — | — | — | — | — | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Walter V. Klemp | Co-Founder, Chairman, President & Chief Executive Officer | 1M | male |
| Jonathan Foster | Executive Vice President & Chief Financial Officer | 672.4K | male |
| Donald H. Picker | Chief Scientific Officer | 544.7K | — |
| John Paul Waymack | Senior Chief Medical Officer | — | — |
| Waldemar Priebe | Co-Founder, Founding Scientist & Chairman of Scientific Advisory Board | — | — |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MBRX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
